Teva Pharmaceutical reported 1.96B in Cost of Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Aspen Pharmacare APN:SJ 998.6B 988.07B
Cipla CIPLA:IN 20.24B 1.22B
Dr.Reddys Laboratories DRRD:IN 19.11B 135M
Guangzhou Baiy 600332:CH 13.81B 1.89B
Jiangsu Hengrui Me. 600276:CH CH 832.63M 22.66M
Kalbe Farma Tbk Pt KLBF:IJ 4046.85B 74.14B
Richter Gedeon RICHT:HB 82.88B 10.82B
Sh Fosun Pharma 600196:CH CH 5.71B 146.53M
Sun Pharmaceuticals SUNP:IN IR 29002M 3605.7M
Teva Pharmaceutical TEVA:IT 1.96B 99M